Articles From: Oxford Immunotec Reports Third Quarter 2014 Financial Results to P&G Declares Quarterly Dividend


2014 Third Quarter Revenue of $13.3 Million Increased 24% Compared to Prior Year Asia Region had 41% Revenue Growth Over Prior Year Net Loss was $6.1 Million for the Third Quarter 1 Millionth Test Processed by Oxford Diagnostics Laboratories in the United States OXFORD, United Kingdom and MARLBOROUGH, Mass., Nov.
Sign-up for Oxford Immunotec Reports Third Quarter 2014 Financial Results investment picks
OXFORD, United Kingdom and MARLBOROUGH, Mass., Oct.
Sign-up for Oxford Immunotec Schedules Third Quarter 2014 Earnings Release and Conference Call for November 4, 2014 investment picks
OXFORD, United Kingdom and MARLBOROUGH, Mass., Nov.
Sign-up for Oxford Immunotec to Host Technology Day investment picks
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1158432&ProfileId=051205&sourceType=1 GREENWICH, CT --
Sign-up for Oxford Lane Capital Corp. Announces Dividend Declaration and Selected Financial Results as of September 30, 2014 investment picks
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1160371&ProfileId=051205&sourceType=1 GREENWICH, CT --
Sign-up for Oxford Lane Capital Corp. Announces Preferred Stock Offering investment picks
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1160713&ProfileId=051205&sourceType=1 GREENWICH, CT --
Sign-up for Oxford Lane Capital Corp. Prices Preferred Stock Offering investment picks
-- Top-Line Growth Driven by Lilly Pulitzer and Tommy Bahama --
Sign-up for Oxford Reports Second Quarter Results investment picks
--Top Line Growth of 11% Led by Tommy Bahama and Lilly Pulitzer-- --Earnings in Line with Company's Expectations--
Sign-up for Oxford Reports Third Quarter Results investment picks
COLUMBUS, Ohio , Oct.
Sign-up for Oxford Resource Partners, LP Reports Third Quarter 2014 Financial Results investment picks
SOUTH SAN FRANCISCO, Calif., Nov.
Sign-up for OXiGENE Announces Issuance of European Patent for OXi4503 in Acute Myeloid Leukemia and other Myeloid Malignancies investment picks
SOUTH SAN FRANCISCO, Calif., Nov.
Sign-up for OXiGENE Announces Preclinical Poster Presentation on OXi4503 at Upcoming American Society of Hematology Meeting investment picks
- Subgroup Analysis of GOG 186I Study Shows Benefit in Difficult-to-Treat Platinum-Resistant Patients - SOUTH SAN FRANCISCO, Calif., Nov.
Sign-up for OXiGENE Announces Presentation of Phase 2 Data Confirming That Addition of Fosbretabulin to Bevacizumab Significantly Increases Progression-Free Survival in Recurrent Ovarian Cancer investment picks
SOUTH SAN FRANCISCO, Calif., Oct.
Sign-up for OXiGENE Announces Third Quarter 2014 Earnings Conference Call and Webcast investment picks
SOUTH SAN FRANCISCO, Calif., Sept.
Sign-up for OXiGENE Initiates Phase 2 Study of Fosbretabulin in Gastrointestinal Neuroendocrine Tumors investment picks
- Positive Data from the Phase 2 GOG 186I Study in Ovarian Cancer Presented at Major Conference - SOUTH SAN FRANCISCO, Calif., Nov.
Sign-up for OXiGENE Reports Third Quarter 2014 Financial Results investment picks
Oxygen Biotherapeutics, Inc. (NASDAQ: OXBT), a specialty pharmaceutical company focused on developing and commercializing a portfolio of products for the critical care market, today announced that the Company received shareholder approval to change the Company name to Tenax Therapeutics, Inc. The name change shall go into effect on Friday, September 19, 2014, and at market open the Company’s common stock will trade on the NASDAQ Capital Market under its new ticker symbol “TENX”. The new CUSIP number for the common stock is 88032L 100 following the name and ticker change.
Sign-up for Oxygen Biotherapeutics Announces Name Change to Tenax Therapeutics (NASDAQ: TENX) investment picks
TONTITOWN, Ark., Oct.
Sign-up for P.A.M. Transport, Inc. Receives Excellence Award From the Environmental Protection Agency investment picks
2014/11/19
Chief claim officers (CCOs) from U.S. property & casualty (P&C) insurance companies said loss cost containment and delivering superior customer service are their top claim operational goals, according to a new P&C Claim Officer Survey conducted by global professional services company Towers Watson (NYSE, NASDAQ: TW). Eighty-nine percent of the CCOs ranked loss cost containment as either their primary or secondary claim operational goal, followed by delivering superior customer service (71%). Survey respondents also emphasized the importance of proactive claim handling.
Sign-up for P&C Insurance Claim Officers Say Loss Cost Containment Is Primary Goal investment picks
2014/10/7
Chief financial officers (CFOs) from North American property & casualty (P&C) insurance companies identified capital utilization as their top business priority, according to a new P&C insurance CFO survey conducted by global professional services company Towers Watson (NYSE, NASDAQ: TW). The CFOs cited preparing for the Own Risk and Solvency Assessment (ORSA) requirements and monitoring progress toward the renewal of the U.S. Terrorism Risk Insurance Act (TRIA) as their next highest priorities.
Sign-up for P&C Insurers Say Capital Utilization Is Top Priority investment picks
MELVILLE, N.Y. , Nov.
Sign-up for P&F Industries Reports Results for the Three and Nine-Month Periods Ended September 30, 2014 investment picks
MELVILLE, N.Y. , Oct.
Sign-up for P&F Repurchases Shares Of Common Stock investment picks
2014/11/11
In honor of Veteran’s Day, Procter & Gamble (P&G) and Walmart are partnering with Jared Allen, defensive end for the Chicago Bears, and his foundation, Jared Allen’s Homes for Wounded Warriors , to help better the lives of Chicago veterans through the support of the Eddie Beard Homeless Veterans’ Housing Program (Vet House). On Nov.
Sign-up for P&G and Walmart Team Up With Chicago Bears’ Jared Allen in Support of Veterans investment picks
2014/10/14
The Board of Directors of The Procter & Gamble Company (NYSE:PG) today declared a quarterly dividend of $0.6436 per share on the Common Stock and on the Series A and Series B ESOP Convertible Class A Preferred Stock of the Company, payable on or after November 17, 2014, to Common Stock shareholders of record at the close of business on October 24, 2014, and to Series A and Series B Preferred Stock shareholders of record at the start of business on October 24, 2014.
Sign-up for P&G Declares Quarterly Dividend investment picks
Premium Membership: Features and Benefits
Wide-Moat Screener for Stocks

Put a moat around your portfolio. Sniff out the most promising opportunities that can ride through any market.

Gold Medalist Screener for Funds

Narrow the available universe of 5000 funds to the top rated gold and silver. Then, sort for manager tenure, expense ratio, risk and return to create your own index-beating fund watchlist.

Thousands of Premium Analyst Reports

While many of our competitors measure a stock's worth with a computer program, Morningstar's staff of 150+ analyst sift through company fillings, financial data and a wealth of other sources to deliver an unvarnished review of any investment. In fact, twelve Morningstar analysts have been recognized by WSJ as "Best on the Street" in the US.

Premium Portfolio Monitor

Make decisions with confidence. Load your investments into our research center and automatically connect to all our proprietary tools and data points.

Mobile

Never be without critical research. Free with your active membership, take our Premium data and guidance wherever you go with Morningstar for iPad®, iPhone®, and Android apps.

Morningstar's Guarantee

We're looking out for you. If after your 14-day free trial, you find that a Morningstar Premium membership is not for you, cancel any time and we'll be happy to refund the unused portion - no questions asked.

Go Premium!
Exclusive Premium Member Benefits
Get the best thinking of 150+ disciplined
objective, experienced analysts-dedicated to
specific industries and securities.
+2,500 Analyst Reports
Wide Moat Screener for Stocks
Medalist Screener for Funds
Premium Portfolio Manager with X-Ray & Monitor
Premium eNewsletters
Morningstar Basic Benefits (All)
Sign up now - No charge for the first 14 days
Articles From: Oxford Immunotec Reports Third Quarter 2014 Financial Results to P&G Declares Quarterly Dividend
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Popularity |  Our Choices |  Most Recent